Literature DB >> 33347771

Does Pollen Trigger Urological Chronic Pelvic Pain Syndrome Flares? A Case-Crossover Analysis in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network.

Irum Javed1,2, Tiange Yu1,2,3, Jieni Li1,2,4, Ratna Pakpahan1, Melissa Milbrandt1,5, Gerald L Andriole6, Jerry L Lowder7, H Henry Lai5,6, Graham A Colditz1, Siobhan Sutcliffe1,7.   

Abstract

PURPOSE: We sought to determine whether pollen triggers urological chronic pelvic pain syndrome flares.
MATERIALS AND METHODS: We assessed flare status every 2 weeks for 1 year as part of the Multidisciplinary Approach to the Study of Chronic Pelvic Pain case-crossover analysis of flare triggers (NCT01098279). Flare symptoms, flare start date and exposures in the 3 days before a flare were queried for the first 3 flares and at 3 randomly selected nonflare times. These data were linked to daily pollen count by date and the first 3 digits of participants' zip codes. Pollen count in the 3 days before and day of a flare, as well as pollen rises past established thresholds, were compared to nonflare values by conditional logistic regression. Poisson regression was used to estimate flare rates in the 3 weeks following pollen rises past established thresholds in the full longitudinal study. Analyses were performed in all participants and separately in those who reported allergies or respiratory tract disorders.
RESULTS: Although no associations were observed for daily pollen count and flare onset, positive associations were observed for pollen count rises past medium or higher thresholds in participants with allergies or respiratory tract disorders in the case-crossover (OR 1.31, 95% CI 1.04-1.66) and full longitudinal (RR 1.23, 95% CI 1.03-1.46) samples.
CONCLUSIONS: We found some evidence to suggest that rising pollen count may trigger flares of urological chronic pelvic pain syndrome. If confirmed in future studies, these findings may help to inform flare pathophysiology, prevention and treatment, and control over the unpredictability of flares.

Entities:  

Keywords:  cystitis, interstitial; pelvic pain; pollen; prostatitis; symptom flare up

Mesh:

Year:  2020        PMID: 33347771      PMCID: PMC9075343          DOI: 10.1097/JU.0000000000001482

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.600


  30 in total

1.  Montelukast for symptom control of interstitial cystitis.

Authors:  Jamie L Traut; Erin S Macdonald; Mikayla L Spangler; Shailendra Saxena
Journal:  Ann Pharmacother       Date:  2011-08-23       Impact factor: 3.154

2.  Estimation of multiple relative risk functions in matched case-control studies.

Authors:  N E Breslow; N E Day; K T Halvorsen; R L Prentice; C Sabai
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

3.  Bladder pain syndrome/interstitial cystitis is associated with asthma: A case-control study.

Authors:  Shiu-Dong Chung; Chung-Chien Huang; Herng-Ching Lin; Li-Ting Kao
Journal:  Neurourol Urodyn       Date:  2018-02-14       Impact factor: 2.696

4.  Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients.

Authors:  Renee Bassaly; Katheryne Downes; Stuart Hart
Journal:  Female Pelvic Med Reconstr Surg       Date:  2011-01       Impact factor: 2.091

5.  The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.

Authors:  K Bouchelouche; J Nordling; T Hald; P Bouchelouche
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

6.  A case-control study of risk factors in men with chronic pelvic pain syndrome.

Authors:  Michel A Pontari; Mary McNaughton-Collins; Michael P O'leary; Elizabeth A Calhoun; Thomas Jang; John W Kusek; J Richard Landis; Jill Knauss; Mark S Litwin
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

7.  Mast Cells in Irritable Bowel Syndrome: A Systematic Review.

Authors:  Luisa Krammer; Anna Sergeevna Sowa; Axel Lorentz
Journal:  J Gastrointestin Liver Dis       Date:  2019-12-09       Impact factor: 2.008

8.  Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome.

Authors:  J Quentin Clemens; Talar Markossian; Elizabeth A Calhoun
Journal:  Urology       Date:  2009-02-04       Impact factor: 2.649

9.  Painful Bladder Syndrome/Interstitial Cystitis Successful Treatment with Montelukast: A Case Report and Literature Review.

Authors:  Muhammad Wajih Ullah; Sunita Lakhani; Sunder Sham; Afshan Rehman; Wardah Siddiq; Tariq Siddiqui
Journal:  Cureus       Date:  2018-06-25

10.  The MAPP research network: design, patient characterization and operations.

Authors:  J Richard Landis; David A Williams; M Scott Lucia; Daniel J Clauw; Bruce D Naliboff; Nancy A Robinson; Adrie van Bokhoven; Siobhan Sutcliffe; Anthony J Schaeffer; Larissa V Rodriguez; Emeran A Mayer; H Henry Lai; John N Krieger; Karl J Kreder; Niloofar Afari; Gerald L Andriole; Catherine S Bradley; James W Griffith; David J Klumpp; Barry A Hong; Susan K Lutgendorf; Dedra Buchwald; Claire C Yang; Sean Mackey; Michel A Pontari; Philip Hanno; John W Kusek; Chris Mullins; J Quentin Clemens
Journal:  BMC Urol       Date:  2014-08-01       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.